Literature DB >> 18019744

Primary hepatic low-grade B-cell lymphoma of MALT-type associated with Helicobacter pylori infection.

Takeshi Iida1, Makoto Iwahashi, Masaki Nakamura, Mikihito Nakamori, Shozo Yokoyama, Masaji Tani, Hiroko Akamatsu, Hirokazu Nakamine, Hiroki Yamaue.   

Abstract

Primary marginal zone B-cell lymphoma of mucosa associated tissue (MALT) type in the liver is extremely rare, and the etiology of this disease is yet to be clarified. We present the first report of a primary hepatic low-grade lymphoma of MALT-type associated with Helicobacter pylori (H. pylori) infection. A 64-year-old man was referred to our hospital for the treatment of early gastric carcinoma. He underwent distal gastrectomy with regional lymph node dissection. In the operation, several small nodules were recognized at the surface of the liver, and one of these hepatic nodules was resected as biopsy. The hepatic lesion exhibited a nodular growth pattern consisting of centrocyte-like cells and intermediate lymphocytes, which were stained with CD20 and CD79a, but not with CD43 or CD45RO. The neoplastic cells form lymphoepithelial lesions infiltrating bile ducts. From these findings the liver lesion was diagnosed as marginal zone B-cell lymphoma of MALT type. Histological examinations of resected stomach and residual stomach showed H. pylori infection. There is a strong association between the presence of H. pylori in the stomach and in the bile, and therefore, the H. pylori may be related to the etiology of primary hepatic MALT type lymphoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18019744

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

Review 1.  Primary hepatic marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type: case report and review of the literature.

Authors:  Hirokazu Doi; Norio Horiike; Atsushi Hiraoka; Yohei Koizumi; Yasunori Yamamoto; Aki Hasebe; Soichi Ichikawa; Makoto Yano; Yasunao Miyamoto; Tomoyuki Ninomiya; Yoshihiro Ishimaru; Masao Miyagawa; Kazuhito Takamura; Hideki Kawasaki; Teruhiko Kozuka; Toshiharu Maeda; Tadashi Yoshino
Journal:  Int J Hematol       Date:  2008-09-23       Impact factor: 2.490

2.  Primary hepatic mucosa-associated lymphoid tissue (MALT) lymphoma.

Authors:  Tetsuya Hamada; Satoru Kakizaki; Hiromi Koiso; Hiroyuki Irisawa; Sumihito Nobusawa; Masatomo Mori
Journal:  Clin J Gastroenterol       Date:  2013-02-07

3.  Primary hepatic mucosa-associated lymphoid tissue lymphoma: case report and literature review.

Authors:  Zhengqi Fu; Lixia Wu; Jiaming Chen; Qichang Zheng; Ping Li; Li Zhang; Chuanming Zhu; Zhengshou Rao; Shaobo Hu
Journal:  Int J Clin Exp Pathol       Date:  2021-03-01

4.  A case of primary hepatic extranodal marginal zone B-cell mucosa-associated lymphoid tissue (MALT) lymphoma treated by radiofrequency ablation (RFA), and a literature review.

Authors:  Zhe Xu; Chong Pang; Jidong Sui; Zhenming Gao
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

5.  Etiological factors in primary hepatic B-cell lymphoma.

Authors:  Kanta Kikuma; Jiro Watanabe; Yumi Oshiro; Tatsuo Shimogama; Yumi Honda; Seiichi Okamura; Koichi Higaki; Naokuni Uike; Tetsuro Soda; Seiya Momosaki; Tadaaki Yokota; Satoshi Toyoshima; Morishige Takeshita
Journal:  Virchows Arch       Date:  2012-03-07       Impact factor: 4.064

6.  Primary hepatic mucosa-associated lymphoid tissue lymphoma: a case report and literature review.

Authors:  Shigeyuki Nagata; Norifumi Harimoto; Kiyoshi Kajiyama
Journal:  Surg Case Rep       Date:  2015-09-24

Review 7.  Primary hepatic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type: A case report and literature review.

Authors:  Shuilin Dong; Lin Chen; Yifa Chen; Xiaoping Chen
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

Review 8.  Primary hepatic mucosa-associated lymphoid tissue lymphoma: A case report and literature review.

Authors:  Huazhi Xie; Jian Lv; Yong Ji; Xinjian Du; Xin Yang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.